Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Duke Law (38)
- University of Oklahoma College of Law (11)
- University of New Hampshire (10)
- Maurer School of Law: Indiana University (9)
- Notre Dame Law School (5)
-
- West Virginia University (5)
- Texas A&M University School of Law (4)
- Louisiana State University Law Center (3)
- University of Georgia School of Law (2)
- University of Maryland Francis King Carey School of Law (2)
- Yeshiva University, Cardozo School of Law (2)
- Aga Khan University (1)
- Brigham Young University (1)
- Brigham Young University Law School (1)
- California Polytechnic State University, San Luis Obispo (1)
- Columbia Law School (1)
- DePaul University (1)
- Marquette University Law School (1)
- Osgoode Hall Law School of York University (1)
- Pace University (1)
- The Catholic University of America, Columbus School of Law (1)
- The University of Akron (1)
- University at Buffalo School of Law (1)
- University of Michigan Law School (1)
- University of Minnesota Law School (1)
- University of Nebraska - Lincoln (1)
- Western Kentucky University (1)
- Keyword
-
- Health & Biotechnology (28)
- Biotechnology (24)
- Patents (11)
- Intellectual property (6)
- Patentability (6)
-
- Bioethics (5)
- DNA (5)
- Synthetic biology (5)
- Biotech (4)
- Patent (4)
- Patent law (4)
- Research (4)
- Agriculture (3)
- Diamond v. Chakrabarty (3)
- Food and Drug Law (3)
- Health Law and Policy (3)
- Human Dignity (3)
- Living matter (3)
- Patent Act (3)
- Science and Technology (3)
- Supreme Court (3)
- Agricultural biotechnology (2)
- Breeders (2)
- Development (2)
- EPC (2)
- European Patent Convention (2)
- FDA (2)
- Farmers (2)
- Free will and determinism (2)
- GMOs (2)
- Publication Year
- Publication
-
- Duke Law & Technology Review (29)
- Faculty Scholarship (12)
- Oklahoma Journal of Law and Technology (8)
- Journal Articles (7)
- RISK: Health, Safety & Environment (1990-2002) (7)
-
- Indiana Law Journal (5)
- Law Faculty Scholarship (5)
- Faculty Articles (3)
- IP Theory (3)
- Texas A&M Law Review (3)
- Cardozo Arts & Entertainment Law Journal (2)
- West Virginia Law Review (2)
- Agriculture Department Seminar Series (1)
- Akron Law Review (1)
- All Papers (1)
- Articles (1)
- Brigham Young University International Law & Management Review (1)
- Buffalo Intellectual Property Law Journal (1)
- Court Briefs (1)
- DePaul Journal of Health Care Law (1)
- Elisabeth Haub School of Law Faculty Publications (1)
- Georgia Journal of International & Comparative Law (1)
- Indiana Journal of Global Legal Studies (1)
- Journal of Contemporary Health Law & Policy (1985-2015) (1)
- Journal of Intellectual Property Law (1)
- Journal of Nonprofit Innovation (1)
- Marquette Intellectual Property Law Review (1)
- Minnesota Journal of Law, Science & Technology (1)
- National Invasive Species Council (1)
- Office of the Provost (1)
- Publication Type
- File Type
Articles 91 - 107 of 107
Full-Text Articles in Biotechnology
The Clone Wars: The Growing Debate Over Federal Cloning Legislation, John Garvish
The Clone Wars: The Growing Debate Over Federal Cloning Legislation, John Garvish
Duke Law & Technology Review
As readers of science fiction are well aware, the term "clone" refers to asexually produced offspring, that is, offspring produced by a process of cell-division which does not begin with the union of two sex cells. A clone is the genetic twin of the cell donor. Propagation of plants by this method is, of course, commonplace, but mammalian reproduction in this fashion would indeed be a revolutionary accomplishment, with profound and disturbing implications.
Where The Wild Wind Blows: Genetically Altered Seed And Neighboring Farmers, Jill Sudduth
Where The Wild Wind Blows: Genetically Altered Seed And Neighboring Farmers, Jill Sudduth
Duke Law & Technology Review
In March 2001, agro-business giant Monsanto won a victory in Canadian Federal Court over Saskatchewan farmer Percy Schmeiser. This case sets international precedent for appropriated seed cases and illustrates the primary concerns American courts must face as they consider Monsanto's prosecution of 22 cases against American farmers.
The Fate Of Gene Patents Under The New Utility Guidelines
The Fate Of Gene Patents Under The New Utility Guidelines
Duke Law & Technology Review
The United States Patent and Trademark Office (PTO) recently finalized its patent utility guidelines. Promulgated by the PTO, the new guidelines will be used by patent examiners in determining whether a claimed invention should be awarded patent protection ;and will be used by patent applicants and attorneys who file patent applications. The guidelines focus primarily on the utility standards for gene and gene fragment patents, an issue that was featured in the PTO's 1999 Revised Interim Utility Guidelines and has been the subject of considerable public debate.
Making Sense Out Of Antisense: The Enablement Requirement In Biotechnology After Enzo Biochem V. Calgene, Matthew D. Kellam
Making Sense Out Of Antisense: The Enablement Requirement In Biotechnology After Enzo Biochem V. Calgene, Matthew D. Kellam
Indiana Law Journal
No abstract provided.
The Gender Of Genetic Futures: The Canadian Biotechnology Strategy, Women And Health, Roxanne Mykitiuk, Fiona Miller, Lorna Weir
The Gender Of Genetic Futures: The Canadian Biotechnology Strategy, Women And Health, Roxanne Mykitiuk, Fiona Miller, Lorna Weir
All Papers
No abstract provided.
Stranger In A Strange Land: Biotechnology And The Federal Circuit, Lawrence M. Sung
Stranger In A Strange Land: Biotechnology And The Federal Circuit, Lawrence M. Sung
Faculty Scholarship
No abstract provided.
Normalizing Novelty: Regulating Biotechnological Risk At The U.S. Epa, Les Levidow, Susan Carr
Normalizing Novelty: Regulating Biotechnological Risk At The U.S. Epa, Les Levidow, Susan Carr
RISK: Health, Safety & Environment (1990-2002)
Drs. Levidow and Carr examine EPA's regulation of biotechnology in the field of genetically modified organisms.
Patents And Cumulative Innovation, Clarisa Long
Patents And Cumulative Innovation, Clarisa Long
Faculty Scholarship
Proprietary rights to the products of biomedical research have repeatedly been a source of controversy for over twenty years. Patents on biomedical innovations have allowed scientists, academics, and research institutions to raise research funds and have contributed to the growth of the biotechnology industry. But “one firm’s research tool may be another firm’s end product.” Patents have been a source of great concern for academic and basic researchers, who fear that proprietary rights to basic research results will hamper the progress of science, stifle the free flow of new knowledge and the dissemination of research results, and chill the research …
Pregnant With Ambiguity: Credibility And The Pto Utility Guidelines In Light Of Brenner, Andrew T. Kight
Pregnant With Ambiguity: Credibility And The Pto Utility Guidelines In Light Of Brenner, Andrew T. Kight
Indiana Law Journal
No abstract provided.
Beyond The Harvard Mouse: Current Patent Practice And The Necessity Of Clear Guidelines In Biotechnology Patent Law, Carrie F. Walter
Beyond The Harvard Mouse: Current Patent Practice And The Necessity Of Clear Guidelines In Biotechnology Patent Law, Carrie F. Walter
Indiana Law Journal
No abstract provided.
Genome Research And Traditional Intellectual Property Protection -- A Bad Fit?, Kate H. Murashige
Genome Research And Traditional Intellectual Property Protection -- A Bad Fit?, Kate H. Murashige
RISK: Health, Safety & Environment (1990-2002)
Dr. Murashige addresses the need for a patent system more closely tailored to the needs of biotechnology. For example, the obviousness requirement may interfere with using patents to recoup high costs of work when it could arguably be done by researchers of ordinary skill.
Paradigms And Our Shrinking Bioethics, Peter Cherbas
Paradigms And Our Shrinking Bioethics, Peter Cherbas
Indiana Law Journal
Symposium: Emerging Paradigms in Bioethihcs
Maximizing The Return From Genome Research: Introduction, Thomas G. Field Jr.
Maximizing The Return From Genome Research: Introduction, Thomas G. Field Jr.
RISK: Health, Safety & Environment (1990-2002)
Professor Field introduces and explains the origins of the symposium.
Biotechnology Process Patents: Is Special Legislation Needed?, Timothy P. Linkkila, Timothy E. Tracy
Biotechnology Process Patents: Is Special Legislation Needed?, Timothy P. Linkkila, Timothy E. Tracy
RISK: Health, Safety & Environment (1990-2002)
The authors review administrative and court decisions prompting proposed changes to the patent law. After reviewing pros and cons, they argue that, on balance, pending bills can easily cause more problems than they solve.
Origins Of The Human Genome Project, Robert Mullan Cook-Deegan
Origins Of The Human Genome Project, Robert Mullan Cook-Deegan
RISK: Health, Safety & Environment (1990-2002)
Dr. Cook-Deegan recounts some of the scientific and political history leading to controversy about the proper mix of private and public roles in pursuing genome research and bringing its fruits to bear, e.g., in preventing and curing disease.
Overview Of Potential Intellectual Property Protection For Biotechnology, Kate H. Murashige
Overview Of Potential Intellectual Property Protection For Biotechnology, Kate H. Murashige
RISK: Health, Safety & Environment (1990-2002)
Dr. Murashige compares the function and value of copyright, patent and trade secret laws in recovering investments in developing genome-related biotechnology.
Book Review, Allan M. Wheatcraft
Book Review, Allan M. Wheatcraft
RISK: Health, Safety & Environment (1990-2002)
Review of the following book: SHELDON KRIMSKY, BIOTECHNICS AND SOCIETY: THE RISE OF INDUSTRIAL GENETICS. (Praeger 1991) [280 pp.] Bibliography, figures, index, list of acronyms used, tables. LC: 90-23214, ISBN: 0-275-93860-3. [Paper $17.95. P.O.B. 5007, Westport CT 06881.]